Retatrutide Side Effects: What Clinical Trials Reveal Retatrutide is a next-generation triple agonist, designed to stimulate the GLP-1, GIP, and glucagon receptors simultaneously. Early studies show remarkable results, with participants losing as much as 24% of their body weight in less than a year when given the highest doses (Jastreboff, New England Journal of Medicine). […]
Retatrutide Half-Life: What It Means for Dosing and Effectiveness Retatrutide is a next-generation triple agonist that targets the GLP-1, GIP, and glucagon receptors simultaneously. This unique mechanism has delivered some of the most dramatic results ever seen in obesity treatment, with participants in Phase 2 trials losing up to 24% of their body weight in […]
When it comes to post-cycle therapy (PCT), controlling estrogen is one of the most critical factors for restoring natural testosterone production, preventing gynecomastia, and protecting long-term hormonal health. While pharmaceutical SERMs like tamoxifen and clomiphene are widely used, they can bring harsh side effects and are not always the best option for long-term balance. That’s […]
Retatrutide is one of the most promising new weight-loss and metabolic health drugs currently in clinical development. Unlike existing GLP-1 receptor agonists such as semaglutide (Wegovy, Ozempic) or dual agonists like tirzepatide (Mounjaro, Zepbound), Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors simultaneously. This unique mechanism has shown unprecedented results in […]
Epitalon is unlike many performance or anti-aging compounds because it doesn’t need to be taken every day to work. Instead, researchers have found that its effects are best achieved through short, cyclical dosing protocols. This is because Epitalon functions as a regulatory peptide — once it activates telomerase, restores melatonin secretion, and adjusts gene expression, the […]